Walleye Capital LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$1,998,000
+100.2%
16,870
+99.6%
0.12%
+73.1%
Q4 2020$998,000
-88.1%
8,453
-89.1%
0.07%
-96.4%
Q1 2020$8,383,000
-2.7%
77,669
+5.0%
1.84%
+230.1%
Q4 2019$8,612,000
+432.3%
74,000
+423.3%
0.56%
+476.3%
Q3 2019$1,618,000
-45.1%
14,140
-54.2%
0.10%
-70.0%
Q2 2019$2,945,00030,9000.32%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders